Modulator of heme biosynthesis induces apoptosis in leukemia cells

J Clin Laser Med Surg. 2001 Apr;19(2):59-67. doi: 10.1089/104454701750285377.

Abstract

Objective: The purpose of this research is the investigation of the possible cause(s) of the dark-cell death phenomenon induced by 1,10-phenanthroline (Oph), a porphyrin biosynthesis modulator.

Summary background data: We have previously shown that porphyrin biosynthesis modulators, such as Oph, which is also an iron-chelating agent, enhance protoporphyrin IX (Proto) accumulation in mammalian neoplastic cells treated with delta-aminolevulinic acid (ALA). As a result of the enhanced Proto accumulation, a significant increase in photodynamic damage was observed under illumination. Also tetrapyrrole and heme-biosynthesis modulators have been shown to cause death in treated insect larvae in darkness, a phenomenon referred to as dark-cell death. Dark-cell death was also observed in Oph + ALA-treated transformed mammalian cells.

Methods: Neoplastic cells were treated with ALA, Oph, and ALA + Oph, and the following cell properties were investigated: growth arrest, membrane permeability, cell survival, nucleosomal cleavage, and cell cycle alterations.

Results: It was observed that Oph but not ALA induced growth arrest, in a T-cell leukemia line (MLA 144) as assessed by reduction in DNA synthesis. Exogenous Proto and isomers of Oph lacking the iron-chelating property of Oph also caused a dose-dependent inhibition of proliferation in MLA 144 cells. Although the plasma membrane of Oph-treated cells remained intact following 3 h of dark-incubation, the cells exhibited DNA internucleosomal cleavage, characteristic of cells undergoing apoptosis. Cell cycle analysis using the DNA intercalating dye propidium iodide (PI) coupled to flow cytometry, indicated that 81 +/- 5.6% of Oph-treated MLA 144 cells were apoptotic, with the majority of the cells arrested in the early S phase. On the other hand, treatment with either ALA or Proto did not alter the cell cycle. Also, using a double-labeling protocol with Hoechst 33342, and PI, and analysis by flow cytometry, Oph-treated cells were found to be 82% apoptotic after 3 h of dark-incubation. Apoptosis was reduced by 75% (p < 0.05) by the cytoplasmic protein synthesis inhibitor cycloheximide.

Conclusions: These results indicate that in addition to enhancing Proto accumulation, the heme biosynthesis modulator Oph also induces growth arrest and apoptosis in transformed cells in darkness.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Aminolevulinic Acid / pharmacology
  • Animals
  • Apoptosis / drug effects*
  • Cell Cycle / drug effects
  • Cell Division / drug effects
  • Cell Membrane Permeability / drug effects
  • Cell Survival / drug effects
  • DNA / biosynthesis
  • Darkness
  • Flow Cytometry
  • Hylobates
  • Iron Chelating Agents / pharmacology
  • Leukemia / metabolism
  • Light
  • Lymphoma / metabolism
  • Matched-Pair Analysis
  • Nucleosomes / drug effects
  • Phenanthrolines / pharmacology
  • Photosensitizing Agents / metabolism
  • Photosensitizing Agents / pharmacology*
  • Protoporphyrins / metabolism
  • Protoporphyrins / pharmacology
  • Receptors, GABA-A / metabolism
  • Tumor Cells, Cultured / drug effects

Substances

  • Iron Chelating Agents
  • Nucleosomes
  • Phenanthrolines
  • Photosensitizing Agents
  • Protoporphyrins
  • Receptors, GABA-A
  • Aminolevulinic Acid
  • DNA
  • protoporphyrin IX
  • 1,10-phenanthroline